Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Journal of the National Cancer Institute

Volumn 95, Issue 13, 2003, Pages

  de Bock, Geertruida H ^a   Tollenaar, Rob A E M ^a   Papelard, Hadewych ^a   Vliet Vlieland, Theodora P M ^a   Devilee, Peter ^a   Cornelisse, Cornelis J ^a   Vandenbroucke, Jan P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; BREAST TUMOR; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; FEMALE; GENETICS; HETEROZYGOTE; HUMAN; MIDDLE AGED; MUTATION; NOTE; RISK; RISK ASSESSMENT; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS;

EID: 0041706683     PISSN: None     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/95.13.1011     Document Type: Note

References (0)